Intérêt de la tomographie à émission de positons au 18fluoro-déoxy-glucose dans la définition des champs de radiothérapie : exemple de la radiothérapie thoracique
- 31 October 2001
- journal article
- review article
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 5 (5) , 685-690
- https://doi.org/10.1016/s1278-3218(01)00127-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- POSITRON EMISSION TOMOGRAPHY IMAGING IN THE THORAXClinics in Chest Medicine, 1999
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999
- Nuclear medicine in cancer diagnosisThe Lancet, 1999
- 18F-Deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasisInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospectsLung Cancer, 1999
- The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer1Lung Cancer, 1998
- Positron Emission Tomography in the Pretreatment Evaluation and Follow-Up of Non-Small Cell Lung Cancer Patients Treated with Radiotherapy: Preliminary FindingsAmerican Journal of Clinical Oncology, 1996
- A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinomaAnnals of Nuclear Medicine, 1996
- Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findingsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1992